IP Library Granted Patent US 9,532,585
Granted Patent B2
US 9,532,585 · App. 10/466,896 · Granted Jan 3, 2017

Ingestible compositions containing an odoriferous oil

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,532,585
App. No.
10/466,896
Granted
Jan 3, 2017
Kind
B2
Abstract

An ingestible composition contained in a soft gel or shard shell capsule includes a digestible odoriferous oil such as a fish oil which can cause reflux or eructation odor problems on the breath of a person taking the capsule. This is reduced by including in the ingestible composition at least one surfactant, preferably in an amount of about 2 to about 20% weight and at least one edible odor-masking ingredient such as parsley seed oil, lemon balm, lemon grass oil, fennel, peppermint oil and/or menthol.

Claims (33)

1. A capsule for delivering an odoriferous oil and having reduced post-ingestion odor, said capsule containing an ingestible composition comprising:

a digestible odoriferous oil selected from a fish oil or a mixture of fish oils;

an edible odor-masking ingredient selected from the group consisting of parsley seed oil, lemon balm, lemon grass oil, fennel oil, peppermint oil, menthol, and combinations thereof; and

an edible surfactant comprising a mixture of at least one hydrophilic surfactant and at least one lipophilic surfactant,

wherein said digestible odoriferous oil is present in an amount ranging from about 30 to about 98% by weight of the ingestible composition,

wherein said edible surfactant is present in an amount ranging from about 2 to about 20% by weight of the ingestible composition,

wherein no water is added to the ingestible composition,

wherein said ingestible composition upon ingestion forms an emulsion in the stomach,

and

wherein the weight ratio of said at least one hydrophilic surfactant to said at least one lipophilic surfactant is in the range of about 1:1.5 to about 1:2.5.

2. The capsule as claimed in claim 1 , wherein the ingestible composition is in a continuous phase.

3. The capsule as claimed in claim 1 , wherein the ingestible composition is a paste.

4. The capsule as claimed in claim 1 , wherein said edible surfactant is present in an amount ranging from about 2 to about 10% by weight of the ingestible composition.

5. The capsule as claimed in claim 4 , wherein said edible surfactant is present in an amount ranging from about 2 to about 7% by weight of the ingestible composition.

6. The capsule as claimed in claim 5 , wherein said edible surfactant is present in an amount ranging from about 5 to about 7% by weight of the ingestible composition.

7. The capsule as claimed in claim 1 , wherein said edible odor-masking ingredient includes at least one odor-masking oil.

8. The capsule as claimed in claim 1 , wherein said edible odor-masking ingredient is present in an amount ranging from about 0.01 to about 5% based on the weight of said at least one digestible odoriferous oil.

9. The capsule as claimed in claim 1 , wherein the at least one hydrophilic surfactant is selected from the group consisting of polyoxyethylene glycerides of C 10 to C 18 fatty acids, polyoxyethylene hydrogenated castor oils, and combinations thereof.

10. The capsule as claimed in claim 1 , wherein the at least one lipophilic surfactant is selected from one or more glycerides of C 5 to C 10 fatty acids.

11. The capsule as claimed in claim 1 , wherein the weight ratio of said at least one hydrophilic surfactant to said at least one lipophilic surfactant is in the range of about 1:1.7 to about 1:2.1.

12. The capsule as claimed in claim 1 , wherein said digestible odoriferous oil is present in an amount ranging from about 75 to about 98% by weight of the ingestible composition.

13. The capsule as claimed in claim 1 , wherein said digestible odoriferous oil is present in an amount ranging from about 85 to about 98% by weight of the ingestible composition.

14. The capsule as claimed in claim 1 , wherein the fish oil comprises cod liver oil.

15. A capsule for delivering an odoriferous oil and having reduced post-ingestion odor, said capsule containing an ingestible composition comprising:

a digestible odoriferous oil selected from a fish oil or a mixture of fish oils;

an edible odor-masking ingredient selected from the group consisting of parsley seed oil, lemon balm, lemon grass oil, fennel oil, peppermint oil, menthol, and combinations thereof; and

an edible surfactant comprising a mixture of a hydrophilic surfactant and a lipophilic surfactant,

wherein said digestible odoriferous oil is present in an amount ranging from about 30 to about 98% by weight of the ingestible composition,

wherein said edible surfactant is present in an amount ranging from about 2 to about 20% by weight of the ingestible composition,

wherein no water is added to the ingestible composition,

wherein said ingestible composition upon ingestion forms an emulsion in the stomach, and

wherein the weight ratio of the hydrophilic surfactant to the lipophilic surfactant is about 1:2.

16. The capsule as claimed in claim 15 , wherein the fish oil comprises cod liver oil.

Assignments (7)
SECURITY INTEREST Recorded Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT WELLNESS NEW JERSEY, LLC; CATALENT MARYLAND, INC.; CATALENT GREENVILLE, INC.; CATALENT MICRON TECHNOLOGIES, INC.; CATALENT SAN DIEGO, INC.; CATALENT WELLNESS VIRGINIA, LLC; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL (019323/0302) Recorded Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; R.P. SCHERER CORPORATION
Reel/Frame 069750/0933 →
NOTICE OF SUCCESSION OF AGENCY Recorded May 17, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 049217/0981 →
CONVERSION Recorded Nov 22, 2016
From: R. P. SCHERER TECHNOLOGIES, INC.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 040670/0027 →
CHANGE OF NAME Recorded Jul 24, 2007
From: CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 409, INC.; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC
To: CATALENT USA WOODSTOCK, INC.; CATALENT USA PACKAGING, LLC; CATALENT PHARMA SOLUTIONS, INC.; CATALENT USA PAINTBALL, INC.; CATALENT PHARMA SOLUTIONS, LLC
Reel/Frame 019588/0622 →
SECURITY AGREEMENT Recorded May 22, 2007
From: PTS ACQUISITION CORP.; PTS INTERMEDIATE HOLDINGS LLC; CARDINAL HEALTH 400, INC.; CARDINAL HEALTH 406, LLC; CARDINAL HEALTH 421, INC.; CARDINAL HEALTH PTS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; GLACIER CORPORATION; CARDINAL HEALTH 409, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 019323/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2004
From: ROWE, DENNIS; GARNETT, KELVIN
To: R.P. SCHERER TECHNOLOGIES, INC.
Reel/Frame 015217/0608 →